LAVAL, QC en CAMBRIDGE, Engeland, 26 september 2023 /PRNewswire/ — Liminal BioSciences Inc. (“Liminal BioSciences” of het “Bedrijf”) is blij te kunnen vermelden dat eerder vandaag de transactie voltooid is die overwogen werd in het eerder aangekondigde wettelijke akkoord onder de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.